Randal J. "RJ" Kirk
54
How'd he get so rich? Kirk is the fast-moving, faster-talking founder of GIV (General Injectibles & Vaccines) and New River Pharmaceuticals, which pioneered the development of the breakthrough ADHD drug Vyvanse. In 2005 he sold New River to Shire, the maker of Adderall, for $2.6 billion. Today he runs private equity firm Third Security, a life sciences venture fund.
About Advertising EDGE Programs Reprints McGraw Hill Careers Terms of Use Disclaimer Privacy Notice Ethics Code Contact Us Site Map Press Room
Copyright 2000-2009 by The McGraw-Hill Companies Inc. All rights reserved.